Breaking News Instant updates and real-time market news.

2020-06-09 06:04:31 CONN Conn's $11.28 / +2.08 (+22.61%) 06:04 06/09/20 06/09 06:04 06/09/20 06:04	Conn's reports Q1 non-GAAP EPS ($1.89), consensus (32c) Reports Q1 revenue $230.6M, consensus $309.86M. E-commerce sales increased over 700% to $5.4M year-over-year. The company commented, "As an essential business, we have maintained store operations throughout the COVID-19 pandemic through a mix of modified operating hours and enhanced employee programs, including temporarily increasing hourly wages by $2 per hour to support our front-line employees and implementing a work from home program for our corporate teams, so that we may continue to assist our customers get the goods they need to shelter-in-place. In addition, we have implemented payment deferral programs to provide relief to credit customers who were economically impacted by COVID-19." And added, "Our Q1 results reflect an increase in our allowance for bad debts of $65.5M, or $1.76 per diluted share, associated with accounting for the COVID-19 pandemic under the new CECL accounting methodology. Despite the loss we recorded for the three months ended April 30 we generated operating cash flows of $152.5M, an increase of over 200% from the prior fiscal year period. We also recently amended our revolving credit facility to help navigate the COVID-19 crisis and had total cash and available liquidity at June 5 of over $295.0M."	09 Jun 23 Jun
CONN Conn's $11.28 / +2.08 (+22.61%) 04/15/20 Stifel Conn's price target lowered to $4.50 from $15 at Stifel 04/15/20 Oppenheimer Conn's downgraded to Perform at Oppenheimer amid COVID-19 pandemic 04/15/20 Oppenheimer Conn's downgraded to Perform from Outperform at Oppenheimer 03/30/20 Stephens Conn's resignation news adds to concerns about credit, says Stephens

2020-06-09 06:04:31

CONN

Conn's

$11.28 / +2.08 (+22.61%)

06:04

06/09/20

06/09

06:04

06/09/20

06:04

Conn's reports Q1 non-GAAP EPS ($1.89), consensus (32c)

Reports Q1 revenue $230.6M, consensus $309.86M. E-commerce sales increased over 700% to $5.4M year-over-year. The company commented, "As an essential business, we have maintained store operations throughout the COVID-19 pandemic through a mix of modified operating hours and enhanced employee programs, including temporarily increasing hourly wages by $2 per hour to support our front-line employees and implementing a work from home program for our corporate teams, so that we may continue to assist our customers get the goods they need to shelter-in-place. In addition, we have implemented payment deferral programs to provide relief to credit customers who were economically impacted by COVID-19." And added, "Our Q1 results reflect an increase in our allowance for bad debts of $65.5M, or $1.76 per diluted share, associated with accounting for the COVID-19 pandemic under the new CECL accounting methodology. Despite the loss we recorded for the three months ended April 30 we generated operating cash flows of $152.5M, an increase of over 200% from the prior fiscal year period. We also recently amended our revolving credit facility to help navigate the COVID-19 crisis and had total cash and available liquidity at June 5 of over $295.0M."

09
Jun
23
Jun

CONN Conn's

$11.28 / +2.08 (+22.61%)

04/15/20 Stifel: Conn's price target lowered to $4.50 from $15 at Stifel

04/15/20 Oppenheimer: Conn's downgraded to Perform at Oppenheimer amid COVID-19 pandemic

04/15/20 Oppenheimer: Conn's downgraded to Perform from Outperform at Oppenheimer

03/30/20 Stephens: Conn's resignation news adds to concerns about credit, says Stephens

TODAY'S FREE FLY STORIES

Downgrade	KBC Group downgraded to Neutral from Outperform at Exane BNP Paribas » 05:21 03/02/21 03/02 05:21 03/02/21 05:21 KBCSY KBC Group $0.00 / + (+0.00%) Exane BNP Paribas analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research KBCSY KBC Group $0.00 / + (+0.00%) 02/24/21 Barclays KBC Group price target raised to EUR 52 from EUR 48 at Barclays 02/17/21 Deutsche Bank KBC Group price target raised to EUR 61 from EUR 60 at Deutsche Bank 02/15/21 Morgan Stanley KBC Group downgraded to Equal Weight from Overweight at Morgan Stanley 02/12/21 UBS KBC Group price target lowered to EUR 48 from EUR 52 at UBS
Upgrade	Tenaris upgraded to Neutral from Underperform at Exane BNP Paribas » 05:20 03/02/21 03/02 05:20 03/02/21 05:20 TS Tenaris $21.56 / +0.62 (+2.96%) Exane BNP Paribas analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings TS Tenaris $21.56 / +0.62 (+2.96%) 11/05/20 Tenaris rises 15.3% TS Tenaris $21.56 / +0.62 (+2.96%) 02/25/21 Piper Sandler Tenaris upgraded to Overweight from Neutral at Piper Sandler 01/25/21 Goldman Sachs Tenaris downgraded to Neutral from Buy at Goldman Sachs 01/11/21 Barclays Tenaris price target raised to EUR 5.90 from EUR 5.30 at Barclays 11/24/20 BofA Tenaris upgraded to Buy from Neutral at BofA TS Tenaris $21.56 / +0.62 (+2.96%) 11/04/20 Tenaris reports Q3 EPS (6c), consensus (16c)
Hot Stocks	Philips appoints Shez Partovi chief innovation and strategy officer » 05:19 03/02/21 03/02 05:19 03/02/21 05:19 PHG Philips $55.04 / +0.54 (+0.99%) , AMZN Amazon.com $3,146.17 / +53.505 (+1.73%) Philips (PHG) announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PHG AMZN PHG Philips $55.04 / +0.54 (+0.99%) 02/18/21 ClearPoint Neuro, Philips enter license and research agreement for Maestro 02/10/21 Investors Bancorp to replace BioTelemetry in S&P 600 at open on 2/10 02/05/21 Garmin wins initial determination in Philips patent dispute 02/04/21 Philips, Dutch SAZ sign five-year strategic partnership AMZN Amazon.com $3,146.17 / +53.505 (+1.73%) 03/01/21 Amazon Prime Video, Eros STX Global confirm Nordics output deal 03/01/21 Verizon, NFL, AWS leverage 5G, MEC for mobile gaming at Super Bowl LV 03/01/21 President Biden tells Amazon not to meddle in union vote 02/24/21 AWS announces general availability of Amazon Lookout for Vision PHG AMZN PHG Philips $55.04 / +0.54 (+0.99%) 01/26/21 Credit Suisse Philips price target raised to EUR 45 from EUR 41 at Credit Suisse 01/26/21 JPMorgan Philips price target raised to EUR 44.90 from EUR 44 at JPMorgan 01/26/21 UBS Philips price target raised to EUR 54 from EUR 51 at UBS 01/25/21 Morgan Stanley iRhythm price target raised to $288 from $227 at Morgan Stanley AMZN Amazon.com $3,146.17 / +53.505 (+1.73%) 02/26/21 B. Riley Securities Plug Power recent selloff provides relative discount, says B. Riley 02/17/21 Needham Kornit Digital price target raised to $125 from $76 at Needham 02/17/21 Morgan Stanley Roku price target raised to $275 from $200 at Morgan Stanley 02/17/21 Citi Citi boosts target on favorite internet stock Amazon to $3,750 PHG AMZN PHG Philips $55.04 / +0.54 (+0.99%) 01/25/21 Philips reports Q4 adjusted EPS EUR 0.94 vs. EUR 0.83 last year 10/19/20 Philips reports Q3 adj. EPS EUR 0.60 vs. EUR 0.46 last year AMZN Amazon.com $3,146.17 / +53.505 (+1.73%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 02/02/21 Amazon.com sees Q1 revenue $100B-$106B , consensus $95.69B 02/02/21 Amazon.com reports Q4 EPS $14.09, consensus $7.23 02/02/21 Notable companies reporting after market close PHG AMZN PHG Philips $55.04 / +0.54 (+0.99%) 01/05/21 Philips shortlists Asian suitors in home appliance unit sale, Bloomberg says AMZN Amazon.com $3,146.17 / +53.505 (+1.73%) 03/01/21 Amazon sued for discrimination, harassment, CNET says 03/01/21 Amazon Prime Video signs Nordics output deal with Eros STX Global, Variety says 03/01/21 Amazon picks Nader Kabbani to lead vaccine rollout, BI reports 02/26/21 Costco to hike minimum hourly wage to $16 an hour, WSJ reports PHG AMZN PHG Philips $55.04 / +0.54 (+0.99%) 01/25/21 Fly Intel: Pre-market Movers 12/18/20 Fly Intel: Wall Street's top stories for Friday 12/18/20 Fly Intel: Wall Street's top stories at midday 10/19/20 Fly Intel: Pre-market Movers AMZN Amazon.com $3,146.17 / +53.505 (+1.73%) 03/01/21 Fly Intel: What to watch in Target's earnings report 02/26/21 Fly Intel: Wall Street's top stories at midday 02/17/21 Under Armour downgrade, Amazon target raise among top calls on Wall Street 02/16/21 Fly Intel: Wall Street's top stories for Tuesday 00:00 Today 2021 London Global Healthcare Virtual Conference 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference AMZN AMZN Amazon.com $3,146.17 / +53.505 (+1.73%) 02/02/21 Amazon options imply 7.6% move in share price post-earnings 12/31/20 Unusually active option classes on open December 31st 12/29/20 Unusually active option classes on open December 29th 10/26/20 Early notable gainers among liquid option names on October 26th
Upgrade	Benchmark Holdings upgraded to Buy from Hold at Kepler Cheuvreux » 05:18 03/02/21 03/02 05:18 03/02/21 05:18 BHCCF Benchmark Holdings $0.00 / + (+0.00%) Kepler Cheuvreux analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research BHCCF Benchmark Holdings $0.00 / + (+0.00%) 01/07/21 Pareto Benchmark Holdings downgraded to Hold from Buy at Pareto
Upgrade	Cargojet upgraded to Outperform from Sector Perform at Scotiabank » 05:17 03/02/21 03/02 05:17 03/02/21 05:17 CGJTF Cargojet $0.00 / + (+0.00%) Scotiabank analyst Konark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals Events CGJTF Cargojet $0.00 / + (+0.00%) 12/23/20 Trudeau says Canada's suspension of passenger flights from UK extended CGJTF Cargojet $0.00 / + (+0.00%) 02/02/21 RBC Capital Cargojet price target raised to C$315 from C$310 at RBC Capital 02/02/21 BMO Capital Cargojet price target raised to C$270 from C$265 at BMO Capital 02/02/21 Scotiabank Cargojet price target raised to C$240 from C$230 at Scotiabank 02/02/21 National Bank Cargojet resumed with an Outperform at National Bank CGJTF Cargojet $0.00 / + (+0.00%) 11/05/20 Canada close to aid package for airlines, Reuters reports 03/15/21 2021 Industrials Virtual Conference

Upgrade	Tim SA upgraded to Sector Perform from Underperform at Scotiabank » 05:17 03/02/21 03/02 05:17 03/02/21 05:17 TIMB Tim SA $11.30 / -0.17 (-1.48%) Scotiabank analyst Andres… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Events TIMB Tim SA $11.30 / -0.17 (-1.48%) 02/23/21 TIM SA trading resumes 02/23/21 Tim SA issues strategic plan for 2021-2023 02/23/21 TIM SA trading halted, news pending TIMB Tim SA $11.30 / -0.17 (-1.48%) 11/26/20 New Street Tim SA initiated with a Buy at New Street 05/06/21 Tim SA - TIMB
Hot Stocks	Elbit Systems awarded $300M contract to provide Hermes 900 to country in Asia » 05:15 03/02/21 03/02 05:15 03/02/21 05:15 ESLT Elbit Systems $133.20 / +5.59 (+4.38%) Elbit Systems announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research ESLT Elbit Systems $133.20 / +5.59 (+4.38%) 02/07/21 Elbit Systems awarded $46M armored personnel carriers contract 02/07/21 Elbit Systems awarded $82M protection systems, electro-optical sights contract 01/26/21 Elbit Systems awarded $172M contract to supply light tanks to Asia Pacific Army 01/21/21 Elbit Systems subsidiary awarded $137M contract by UK Ministry of Defence ESLT Elbit Systems $133.20 / +5.59 (+4.38%) 11/18/20 Jefferies Elbit Systems downgraded to Hold on defense slowdown at Jefferies 11/18/20 Jefferies Elbit Systems downgraded to Hold from Buy at Jefferies
Hot Stocks	Motorola Solutions awarded contract by HDO HF for CRS » 05:12 03/02/21 03/02 05:12 03/02/21 05:12 MSI Motorola Solutions $182.21 / +6.28 (+3.57%) Motorola Solutions… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Options MSI Motorola Solutions $182.21 / +6.28 (+3.57%) 02/17/21 Motorola Solutions opens new facility in Richardson, Texas 12/08/20 Verizon, Motorola Solutions announce Group First Response solution 11/19/20 Motorola Solutions raises quarterly dividend by 11% to 71c per share 11/16/20 Omega takes Alphabet Class A stake, exits position in JPMorgan MSI Motorola Solutions $182.21 / +6.28 (+3.57%) 02/05/21 Cowen Motorola Solutions price target raised to $216 from $183 at Cowen 02/05/21 Barclays Motorola Solutions price target raised to $206 from $196 at Barclays 02/05/21 Citi Motorola Solutions price target raised to $210 from $190 at Citi 01/29/21 Jefferies Carvana, Walmart among 13 additions to Jefferies Franchise Picks list MSI Motorola Solutions $182.21 / +6.28 (+3.57%) 02/04/21 Motorola Solutions sees FY21 adjusted EPS $8.50-$8.62, consensus $8.58 02/04/21 Motorola Solutions sees Q1 adjusted EPS $1.58-$1.64, consensus $1.52 02/04/21 Motorola Solutions reports Q4 adjusted EPS $2.86, consensus $2.74 10/29/20 Motorola Solutions ups FY20 adj. EPS view to $7.52-$7.58 from $7.40-$7.52 MSI Motorola Solutions $182.21 / +6.28 (+3.57%) 01/12/21 Judge cuts Motorola Solutions award from Hytera by $221M, Bloomberg says MSI Motorola Solutions $182.21 / +6.28 (+3.57%) 10/15/20 Early notable gainers among liquid option names on October 15th
Initiation	Terns Pharmaceuticals initiated with a Buy at Goldman Sachs » 05:11 03/02/21 03/02 05:11 03/02/21 05:11 TERN Terns Pharmaceuticals $24.21 / +1.38 (+6.04%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Syndicate On The Fly 05 Feb TERN Terns Pharmaceuticals $24.21 / +1.38 (+6.04%) 02/07/21 Opening Day: Sana raises largest-ever IPO for preclinical biotech
Recommendations	uniQure price target raised to $100 from $85 at Chardan » 05:09 03/02/21 03/02 05:09 03/02/21 05:09 QURE uniQure $38.03 / +1.39 (+3.79%) Chardan analyst Gbola… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly QURE uniQure $38.03 / +1.39 (+3.79%) 03/01/21 uniQure expects cash to fund operations into 2H22 02/08/21 uniQure says DSMB recommends proceeding with Phase I/II trial of AMT-130 12/21/20 uniQure says hemophilia B gene therapy program placed on clinical hold 12/08/20 uniQure presents late-breaking data from Phase III HOPE-B trial QURE uniQure $38.03 / +1.39 (+3.79%) 12/22/20 Chardan uniQure selloff on clinical hold brings good entry point, says Chardan 12/22/20 Jefferies uniQure's EtranaDez unlikely to raise HCC risk in hemB patients, says Jefferies 12/22/20 RBC Capital uniQure price target lowered to $53 from $61 at RBC Capital 12/22/20 H.C. Wainwright uniQure price target lowered to $80 from $85 at H.C. Wainwright QURE uniQure $38.03 / +1.39 (+3.79%) 03/01/21 uniQure reports 2020 EPS ($2.81), consensus ($1.25) 10/27/20 uniQure reports Q3 EPS ($1.21) vs. (58c) last year QURE uniQure $38.03 / +1.39 (+3.79%) 12/21/20 Fly Intel: Wall Street's top stories for Monday 12/21/20 Fly Intel: Wall Street's top stories at midday 11/11/20 Hilton upgrade, AIG downgrade among today's top calls on Wall Street

Hot Stocks	G. Willi-Food CEO Einat Shapira to resign » 05:09 03/02/21 03/02 05:09 03/02/21 05:09 WILC G. Willi-Food $24.48 / +0.47 (+1.96%) G. Willi-Food announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Recommendations	Piper lowers Inovio target to $7 after 'decidedly negative' update » 05:08 03/02/21 03/02 05:08 03/02/21 05:08 INO Inovio $11.64 / +0.52 (+4.68%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options INO Inovio $11.64 / +0.52 (+4.68%) 03/01/21 Inovio reports REVEAL 1 trial met primary, secondary endpoints 02/24/21 Qiagen, Inovio expand collaboration to develop NGS companion diagnostic 02/23/21 Inovio doses first patient in Phase 1B clinical trial for INO-4500 01/06/21 Inovio reports positive efficacy results from Phase 2 trial of VGX-3100 INO Inovio $11.64 / +0.52 (+4.68%) 02/11/21 Oppenheimer Opco starts DNA medicines 'disruptor' Inovio with buy, $35 price target 02/11/21 Oppenheimer Inovio initiated with an Outperform at Oppenheimer 02/09/21 Maxim Heat data puts cancer vaccine discussion 'back on the table,' says Maxim 01/08/21 Benchmark Inovio price target lowered to $15 from $25 at Benchmark INO Inovio $11.64 / +0.52 (+4.68%) 03/01/21 Inovio reports Q4 EPS (14c), consensus (22c) 11/09/20 Inovio reports Q3 EPS 11c, consensus (19c) 21 Jan INO Inovio $11.64 / +0.52 (+4.68%) 10/02/20 White House officials raise objections to FDA vaccine approval plans, WSJ says 09/29/20 Citron lowers Inovio price target to $2 after FDA hold news 09/23/20 U.K. to test vaccines on volunteers deliberately infected with COVID, FT reports 09/23/20 Inovio shares are going back to $5, Citron Research says INO Inovio $11.64 / +0.52 (+4.68%) 03/01/21 Fly Intel: After-Hours Movers 02/12/21 Initiation of 'disrupter' Inovio among today's top calls on Wall Street 02/12/21 Fly Intel: Pre-market Movers 01/21/21 Fly Intel: Pre-market Movers 03/04/21 M-Vest Virtual Conference Series: Late Stage Innovations in Women's Health 03/15/21 33rd Annual Roth Virtual Conference 03/16/21 31st Annual Healthcare Virtual Conference INO Inovio $11.64 / +0.52 (+4.68%) 03/01/21 Inovio options imply 19.7% move in share price post-earnings 02/23/21 Inovio put volume heavy and directionally bearish 02/12/21 Unusually active option classes on open February 12th 02/01/21 Inovio call volume above normal and directionally bullish
Hot Stocks	Motional selects Ambarella CVflow AI processors for driverless vehicles » 05:06 03/02/21 03/02 05:06 03/02/21 05:06 AMBA Ambarella $118.61 / +6.12 (+5.44%) Ambarella announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options AMBA Ambarella $118.61 / +6.12 (+5.44%) 01/11/21 Ambarella unveils CV5 AI vision processor with 8K capabilities 12/28/20 FAA adopts final rules for drones 'advancing opportunities' for utilization 12/02/20 AWS partnering with Nvidia and Ambarella to enable AWS Panorama Device SDK 12/01/20 Ambarella CTO sells 20K shares of common stock AMBA Ambarella $118.61 / +6.12 (+5.44%) 02/24/21 Deutsche Bank Ambarella price target raised to $100 from $75 at Deutsche Bank 01/21/21 Stifel Ambarella price target raised to $118 from $110 at Stifel 01/13/21 Roth Capital Ambarella upgraded to Buy with $130 price target at Roth Capital 01/13/21 Roth Capital Ambarella upgraded to Buy from Neutral at Roth Capital AMBA Ambarella $118.61 / +6.12 (+5.44%) 11/24/20 Ambarella sees Q4 revenue $56M-$60M, consensus $52.31M 11/23/20 Ambarella reports Q3 EPS 9c, consensus 5c 09/02/20 Ambarella sees Q3 revenue $52M-$56M, consensus $55.12M 09/02/20 Ambarella reports Q2 EPS 6c, consensus (2c) AMBA Ambarella $118.61 / +6.12 (+5.44%) 12/14/20 Fly Insider: Molecular Templates, AMD among notable insider trades 12/07/20 Fly Insider: Foot Locker, Alexion among weeks notable insider trades 11/23/20 Fly Intel: After-Hours Movers 09/02/20 Fly Intel: After-Hours Movers 03/15/21 33rd Annual Roth Virtual Conference 16:30 Today Ambarella - AMBA AMBA Ambarella $118.61 / +6.12 (+5.44%) 02/01/21 Ambarella call volume above normal and directionally bullish 01/21/21 Ambarella call volume above normal and directionally bullish 12/10/20 Ambarella call volume above normal and directionally bullish 12/03/20 Ambarella call volume above normal and directionally bullish
Recommendations	Sarepta price target lowered to $130 from $140 at Piper Sandler » 05:05 03/02/21 03/02 05:05 03/02/21 05:05 SRPT Sarepta $86.94 / -0.07 (-0.08%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SRPT Sarepta $86.94 / -0.07 (-0.08%) 02/25/21 Sarepta rallies 2% to $86.15 after winning FDA approval for DMD treatment 02/25/21 Sarepta announces FDA approval of Amondys 45 02/08/21 Dyne Therapeutics appoints Ashish Dugar as SVP, global head of medical affairs 01/13/21 Sarepta, Genevant announce collaboration for gene editing therapeutics SRPT Sarepta $86.94 / -0.07 (-0.08%) 02/26/21 Mizuho Sarepta price target raised to $160 from $158 at Mizuho 02/25/21 Piper Sandler Piper says Sarepta's Amondys 45 approval comes with 'relatively clean label' 02/09/21 Morgan Stanley Sarepta denied motion to dismiss 'Wilson Wolf' case, says Morgan Stanley 01/12/21 Citi Sarepta downgraded to Neutral from Buy at Citi SRPT Sarepta $86.94 / -0.07 (-0.08%) 03/01/21 Sarepta reports Q4 EPS ($1.84), consensus ($1.77) 03/01/21 Sarepta reports Q4 EPS ($1.84), consensus ($1.77) 11/05/20 Sarepta reports Q3 EPS ($2.50), consensus ($1.71) SRPT Sarepta $86.94 / -0.07 (-0.08%) 03/01/21 Fly Intel: After-Hours Movers 01/12/21 NIO downgrade, Wells Fargo upgrade among today's top calls on Wall Street 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 00:00 Today 41st Annual Healthcare Virtual Conference
Initiation	Immunocore initiated with a Neutral at Goldman Sachs » 05:04 03/02/21 03/02 05:04 03/02/21 05:04 IMCR Immunocore $50.10 / +2.77 (+5.85%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Syndicate On The Fly IMCR Immunocore $50.10 / +2.77 (+5.85%) 02/19/21 Immunocore's tebentafusp granted Breakthrough Therapy Designation 05 Feb IMCR Immunocore $50.10 / +2.77 (+5.85%) 02/07/21 Opening Day: Sana raises largest-ever IPO for preclinical biotech

Recommendations	Dicerna price target raised to $34 from $25 at Chardan » 05:04 03/02/21 03/02 05:04 03/02/21 05:04 DRNA Dicerna $28.88 / +1.86 (+6.88%) Chardan analyst Keay… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly DRNA Dicerna $28.88 / +1.86 (+6.88%) 02/11/21 Dicerna initiates dosing in clinical trial of nedosiran for PH3 01/05/21 Dicerna announces first Novo Nordisk nominated candidate under agreement 01/04/21 Dicerna reports enrollment completion of PHYOX2 nedosiran trial 11/16/20 Dicerna gets $10M milestone from Lilly pact, Lilly initiates LY3561774 trial DRNA Dicerna $28.88 / +1.86 (+6.88%) 03/01/21 B. Riley Securities Dicerna price target raised to $40 from $37 at B. Riley Securities 01/11/21 B. Riley Securities Dicerna price target raised to $37 from $30 at B. Riley Securities 08/07/20 H.C. Wainwright Dicerna price target raised to $35 from $32 at H.C. Wainwright 07/01/20 Baird Dicerna elevated to Fresh Pick at Baird DRNA Dicerna $28.88 / +1.86 (+6.88%) 02/25/21 Dicerna reports FY20 EPS ($1.52), consensus ($1.05) 11/05/20 Dicerna reports Q3 EPS (29c), consensus (20c) DRNA Dicerna $28.88 / +1.86 (+6.88%) 02/25/21 Fly Intel: After-Hours Movers
Downgrade	Brasileira de Distribuicao downgraded to Neutral from Buy at Goldman Sachs » 05:00 03/02/21 03/02 05:00 03/02/21 05:00 CBD Companhia Brasileira de Distribuicao $16.49 / +1.515 (+10.12%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News CBD Companhia Brasileira de Distribuicao $16.49 / +1.515 (+10.12%) 09/10/20 Companhia Brasileira de Distribuicao rises 13.6% 09/10/20 Companhia Brasileira de Distribuicao rises 16.0% 09/10/20 Companhia Brasileira de Distribuicao rises 16.9%
Initiation	Vor Biopharma initiated with a Sell at Goldman Sachs » 04:59 03/02/21 03/02 04:59 03/02/21 04:59 VOR Vor Biopharma $48.00 / +3.06 (+6.81%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly Events VOR Vor Biopharma $48.00 / +3.06 (+6.81%) 02/09/21 Vor Biopharma Chairman Parmar purchased $10M in company shares VOR Vor Biopharma $48.00 / +3.06 (+6.81%) 02/10/21 Piper Sandler PureTech Health price target raised to $76 from $66 at Piper Sandler 05 Feb VOR Vor Biopharma $48.00 / +3.06 (+6.81%) 02/07/21 Opening Day: Sana raises largest-ever IPO for preclinical biotech 00:00 Today 41st Annual Healthcare Virtual Conference
Initiation	Gemini Therapeutics initiated with a Buy at Goldman Sachs » 04:56 03/02/21 03/02 04:56 03/02/21 04:56 GMTX Gemini Therapeutics $15.60 / +0.44 (+2.90%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Options GMTX Gemini Therapeutics $15.60 / +0.44 (+2.90%) 02/10/21 Gemini Therapeutics completes enrollment in Phase 2a Trial of GEM103 02/09/21 Gemini Therapeutics appoints Brian Piekos as CFO 02/08/21 Gemini Therapeutics completes business combination with FSDC, debuts on Nasdaq GMTX Gemini Therapeutics $15.60 / +0.44 (+2.90%) 02/16/21 Stifel Gemini Therapeutics initiated with a Buy at Stifel GMTX Gemini Therapeutics $15.60 / +0.44 (+2.90%) 02/09/21 Five new option listings and two option delistings on February 9th
Recommendations	Align Technology pullback brings attractive entry point, says Piper Sandler » 04:55 03/02/21 03/02 04:55 03/02/21 04:55 ALGN Align Technology $565.06 / -4.05 (-0.71%) Shares of Align… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options ALGN Align Technology $565.06 / -4.05 (-0.71%) 02/25/21 Align Technology announces partnership with Golden State Warriors 02/22/21 Zimmer Biomet names Align Technology CDO to board 01/20/21 Align Technology establishes global corporate headquarters in Tempe 11/18/20 Align says ITC reverses ALJ finding that 3Shape indirectly Infringed patent ALGN Align Technology $565.06 / -4.05 (-0.71%) 02/04/21 Evercore ISI Align Technology price target raised to $680 from $625 at Evercore ISI 02/04/21 Credit Suisse Align Technology price target raised to $630 from $618 at Credit Suisse 02/04/21 Barclays Align Technology price target raised to $555 from $475 at Barclays 02/04/21 Piper Sandler Align Technology price target raised to $700 from $610 at Piper Sandler ALGN Align Technology $565.06 / -4.05 (-0.71%) 02/03/21 Align Technology reports Q4 EPS $2.61, consensus $2.14 02/03/21 Align Technology reports Q4 EPS $2.61, consensus $2.14 02/03/21 Notable companies reporting after market close 10/21/20 Align Technology reports Q3 EPS $2.25, consensus 54c ALGN Align Technology $565.06 / -4.05 (-0.71%) 02/03/21 Fly Intel: After-Hours Movers 11/02/20 Fly Insider: Live Oak Bancshares, Zoom Video among week's notable insider trades 10/22/20 Fly Intel: Wall Street's top stories for Thursday 10/22/20 Fly Intel: Wall Street's top stories at midday ALGN Align Technology $565.06 / -4.05 (-0.71%) 02/04/21 Early notable gainers among liquid option names on February 4th 02/03/21 Align Technology options imply 14.3% move in share price post-earnings 10/28/20 Align Technology put volume heavy and directionally bearish

Conference/Events	The Genome Partnership to hold a virtual meeting » 04:55 03/02/21 03/02 04:55 03/02/21 04:55 NSTG NanoString $74.48 / +4.46 (+6.37%) , TWST Twist Bioscience $145.03 / +7.29 (+5.29%) , PACB Pacific Biosciences $35.25 / +4.68 (+15.31%) , QGEN Qiagen $50.35 / +0.3 (+0.60%) , TXG 10x Genomics $186.79 / +8.82 (+4.96%) , CDXS Codexis $23.48 / +1.3 (+5.86%) , PKI PerkinElmer $129.77 / +3.58 (+2.84%) , ILMN Illumina $446.26 / +6.68 (+1.52%) , RHHBY Roche $0.00 / + (+0.00%) , BNGO Bionano Genomics $9.84 / +0.105 (+1.08%) Advances in Genome… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 7 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options NSTG TWST PACB QGEN TXG CDXS PKI ILMN RHHBY BNGO NSTG NanoString $74.48 / +4.46 (+6.37%) 02/22/21 NanoString announces launch of Whole Transcriptome Atlas 11/17/20 NanoString, OHSU partner on GeoMx-based spatial profiling assays 09/09/20 NanoString announces new GeoMx COVID-19 consortium TWST Twist Bioscience $145.03 / +7.29 (+5.29%) 02/18/21 Twist Bioscience and VCGS in development pact for diagnostic assay 02/03/21 Twist Bioscience announces promotions including Siyuan Chen as CTO 01/19/21 Twist Bioscience enters two licensing agreements with Serotiny, Applied StemCell 01/14/21 Twist Bioscience begins shipping new synthetic RNA reference controls PACB Pacific Biosciences $35.25 / +4.68 (+15.31%) 02/24/21 Children's Mercy Kansas City implements four PacBio Sequel IIe Systems 02/18/21 Pacific Biosciences announces LabCorp's addition of PacBio Sequel II Systems 02/10/21 Pacific Biosciences reports Q4 EPS 40c, consensus 32c 02/10/21 Pacific Biosciences announces $900M investment from SoftBank QGEN Qiagen $50.35 / +0.3 (+0.60%) 02/24/21 Qiagen, Inovio expand collaboration to develop NGS companion diagnostic 02/16/21 Paulson & Co. buys Exxon, exits Qiagen in Q4 02/10/21 Qiagen CEO says will consider potential 'bolt-on acquisitions' 02/09/21 Quidel CEO tells Bloomberg won't enter deal without 'obvious strategic fit' TXG 10x Genomics $186.79 / +8.82 (+4.96%) 02/16/21 Third Point buys Upstart, exits Caesars in Q4 10/05/20 10x Genomics acquires ReadCoor for $350M 09/15/20 10x Genomics shipping Chromium Single Cell Multiome ATAC + Gene Expression CDXS Codexis $23.48 / +1.3 (+5.86%) 01/13/21 Codexis, Tate & Lyle expand relationship to enhance stevia, allulose production PKI PerkinElmer $129.77 / +3.58 (+2.84%) 02/23/21 PerkinElmer launches point of care Covid-19 antigen test for mass screening 02/22/21 PerkinElmer gives update on Valencia Branch Laboratory's accreditation process 02/16/21 Organogenesis appoints David Francisco as CFO 01/14/21 PerkinElmer SARS-CoV-2 RT-PCR assay receives FDA EUA for asymptomatic testing ILMN Illumina $446.26 / +6.68 (+1.52%) 02/19/21 Illumina, University Hospital of Tubingen to evaluate WGS potential 02/08/21 Illumina accelerator invests in nine genomics startups for second global cycle 02/04/21 Illumina announces agreement with Belgian Society of Medical Oncology 01/20/21 Illumina wins patent infringement suit against BGI in U.K. RHHBY Roche $0.00 / + (+0.00%) 02/26/21 Regeneron announces CHMP recommendation for COVID-19 antibody cocktail 02/24/21 Prothena announces presentation of new preclinical PRX005 data 02/19/21 Atea Pharmaceuticals announces Chugai in-license of AT-527 from Roche 02/12/21 Genentech announces results from four Phase III studies of faricimab BNGO Bionano Genomics $9.84 / +0.105 (+1.08%) 02/22/21 Bionano Genomics announces publication on genome-wide model 02/11/21 Bionano Genomics announces publication on method for optical genome mapping 02/09/21 Bionano Genomics' Saphyr adopted by Canada's largest hospital diagnostic lab 02/02/21 Bionano Genomics announces publication of study on DNA methylation NSTG TWST PACB QGEN TXG CDXS PKI ILMN RHHBY BNGO NSTG NanoString $74.48 / +4.46 (+6.37%) 01/11/21 Baird NanoString price target raised to $70 from $60 at Baird 01/06/21 Cowen NanoString upgraded to Outperform with $75 target at Cowen 01/06/21 Cowen NanoString upgraded to Outperform from Market Perform at Cowen 12/02/20 JPMorgan NanoString price target raised to $60 from $45 at JPMorgan TWST Twist Bioscience $145.03 / +7.29 (+5.29%) 02/05/21 Baird Twist Bioscience price target raised to $200 from $125 at Baird 02/05/21 JPMorgan Twist Bioscience downgraded to Underweight from Neutral at JPMorgan 01/04/21 Evercore ISI Evercore ISI cuts Twist Bioscience to In Line, says new verticals take time 01/04/21 Evercore ISI Twist Bioscience downgraded to In Line from Outperform at Evercore ISI PACB Pacific Biosciences $35.25 / +4.68 (+15.31%) 02/11/21 Cantor Fitzgerald Pacific Biosciences price target raised to $62 from $45 at Cantor Fitzgerald 02/11/21 Piper Sandler Pacific Biosciences upgraded to Overweight from Neutral at Piper Sandler 01/15/21 Piper Sandler Pacific Biosciences price target raised to $20 from $12 at Piper Sandler 01/12/21 Cantor Fitzgerald Pacific Biosciences price target raised to $45 from $25 at Cantor Fitzgerald QGEN Qiagen $50.35 / +0.3 (+0.60%) 02/19/21 Berenberg Qiagen price target raised to EUR 56 from EUR 52 at Berenberg 02/09/21 William Blair Quidel, Qiagen merger would not make sense, says William Blair 02/09/21 Wells Fargo Qiagen shares should be sold on latest merger talk, says Wells Fargo 02/09/21 Citi Merger with Qiagen would benefit Quidel, says Citi TXG 10x Genomics $186.79 / +8.82 (+4.96%) 02/18/21 Cowen 10x Genomics price target raised to $200 from $155 at Cowen 02/18/21 JPMorgan 10x Genomics price target raised to $195 from $160 at JPMorgan 02/18/21 Citi 10x Genomics price target raised to $240 from $195 at Citi 12/16/20 Citi 10x Genomics price target raised to $195 from $165 at Citi CDXS Codexis $23.48 / +1.3 (+5.86%) 03/01/21 Stifel Codexis initiated with a Buy at Stifel 12/30/20 Benchmark Codexis price target raised to $29 from $21 at Benchmark 07/15/20 Stephens Codexis resumed with an Overweight at Stephens 03/10/20 Benchmark Codexis initiated with a Buy at Benchmark PKI PerkinElmer $129.77 / +3.58 (+2.84%) 02/03/21 Citi PerkinElmer price target raised to $155 from $150 at Citi 01/07/21 Piper Sandler Oxford Immunotec downgraded to Neutral from Overweight at Piper Sandler 01/07/21 Wells Fargo PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo 01/07/21 Wells Fargo PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo ILMN Illumina $446.26 / +6.68 (+1.52%) 02/16/21 BTIG Illumina price target raised to $570 from $410 at BTIG 02/12/21 Piper Sandler Illumina price target raised to $510 from $415 at Piper Sandler 02/12/21 Cowen Illumina price target raised to $460 from $385 at Cowen 12/22/20 Fly Intel: Top five analyst upgrades RHHBY Roche $0.00 / + (+0.00%) 02/25/21 Berenberg Roche price target lowered to CHF 320 from CHF 325 at Berenberg 02/24/21 Morgan Stanley Roche price target lowered to CHF 345 from CHF 365 at Morgan Stanley 02/23/21 BofA BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list 02/17/21 UBS UBS downgrades Roche to Neutral on risk to 2022 estimates BNGO Bionano Genomics $9.84 / +0.105 (+1.08%) 02/08/21 Oppenheimer Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer 01/26/21 Ladenburg Bionano Genomics price target raised to $14 from $1.25 at Ladenburg 01/22/21 Maxim Bionano Genomics price target raised to $14 from $2 at Maxim 12/04/20 Roth Capital Bionano Genomics downgraded to Neutral from Buy at Roth Capital NSTG TWST PACB QGEN TXG CDXS PKI ILMN RHHBY BNGO NSTG NanoString $74.48 / +4.46 (+6.37%) 03/01/21 NanoString sees FY21 revenue $140M-$150M, consensus $151.03M 03/01/21 NanoString reports Q4 EPS (53c), consensus (49c) 01/10/21 NanoString sees Q4 product/service revenue $35.7M, consensus $33.36M 11/09/20 NanoString reports Q3 EPS (56c), consensus (60c) TWST Twist Bioscience $145.03 / +7.29 (+5.29%) 02/04/21 Twist Bioscience backs FY21 revenue view $110M-$118M, consensus $116.02M 02/04/21 Twist Bioscience reports Q1 EPS (72c), consensus (74c) 11/23/20 Twist Bioscience sees Q1 revenue $25M-$26M 11/23/20 Twist Bioscience sees FY21 revenue $110M-$118M, consensus $117.9M PACB Pacific Biosciences $35.25 / +4.68 (+15.31%) 01/11/21 Pacific Biosciences sees Q4 revenue $27M, consensus $23.69M 11/02/20 Pacific Biosciences reports Q3 EPS (14c), consensus (13c) QGEN Qiagen $50.35 / +0.3 (+0.60%) 02/09/21 Qiagen backs FY21 EPS view $2.42-$2.46, consensus $2.40 02/09/21 Qiagen reports Q4 EPS 68c, consensus 65c 12/08/20 Qiagen sees FY21 adj. EPS $2.42-$2.46 CER, consensus $2.40 12/08/20 Qiagen raises FY20 adj. EPS view to $2.13-$2.14 CER from $2.07-$2.09 CER TXG 10x Genomics $186.79 / +8.82 (+4.96%) 02/17/21 10x Genomics sees FY21 revenue $480M-$500M, consensus $494.02M 02/17/21 10x Genomics reports Q4 EPS ($3.87), consensus (23c) 11/10/20 10x Genomics reports Q3 EPS (65c), consensus (30c) CDXS Codexis $23.48 / +1.3 (+5.86%) 02/25/21 Codexis sees FY21 revenue $82M-$85M, consensus $80.53M 02/25/21 Codexis reports Q4 EPS (6c), consensus (12c) 11/05/20 Codexis reports Q3 EPS (10c), consensus (11c) PKI PerkinElmer $129.77 / +3.58 (+2.84%) 02/02/21 PerkinElmer sees Q1 adjusted EPS of at least $3.00, consensus $2.40 02/02/21 PerkinElmer sees FY21 adjusted EPS at least $8.50, consensus $8.88 02/02/21 PerkinElmer reports Q4 adjusted EPS $3.96, consensus $3.00 01/11/21 PerkinElmer sees Q4 adjusted EPS 'at least' $3.60, consensus $2.79 ILMN Illumina $446.26 / +6.68 (+1.52%) 02/11/21 Illumina sees FY21 adjusted EPS $5.10-$5.35, consensus $6.11 02/11/21 Illumina reports Q4 adjusted EPS $1.22, consensus $1.11 02/11/21 Notable companies reporting after market close 01/11/21 Illumina sees FY21 adjusted EPS $5.10-$5.35, consensus $6.61 RHHBY Roche $0.00 / + (+0.00%) 02/04/21 Roche reports 2020 core EPS CHF 19.16 vs. CHF 20.16 last year 10/27/20 Oncolytics announces new GI cancer study using 10/15/20 Roche confirms outlook for 2020 based on assessment of COVID-19 10/15/20 Roche reports 9 months group sales CHF43.98B vs. CHF46.07B last year BNGO Bionano Genomics $9.84 / +0.105 (+1.08%) 11/12/20 Bionano Genomics reports Q3 revenue $2.2M, consensus $2.07M. 10/15/20 Bionano Genomics sees Q3 revenue $1.9M-$2.3M, consensus $2.07M 20 Jan 08 Jan 03 Dec 03 Dec 11 Nov 08 Oct 11 Sep 12 Aug 04 Jun PACB QGEN ILMN RHHBY PACB Pacific Biosciences $35.25 / +4.68 (+15.31%) 02/23/21 Sources claim Softbank plans 'billions' in investment in biotech, Bloomberg says 02/10/21 SoftBank to invest $900M in Pacific Biosciences, WSJ reports 01/08/21 SoftBank has taken 6% stake in Pacific Biosciences, Bloomberg reports 01/08/21 Pacific Biosciences jumps after Bloomberg says SoftBank takes 6% stake QGEN Qiagen $50.35 / +0.3 (+0.60%) 02/08/21 Quidel weighs combining with Qiagen, Bloomberg reports 02/08/21 Qiagen jumps after Bloomberg says Quidel made preliminary approach 02/08/21 Quidel weighs combining with Qiagen, Bloomberg reports ILMN Illumina $446.26 / +6.68 (+1.52%) 09/16/20 Illumina near deal to acquire cancer testing company Grail, Bloomberg reports RHHBY Roche $0.00 / + (+0.00%) 02/11/21 Roche arthritis drug reduced Covid deaths in study, Reuters reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports NSTG TWST PACB QGEN TXG CDXS PKI ILMN RHHBY BNGO NSTG NanoString $74.48 / +4.46 (+6.37%) 10/06/20 Fly Intel: After-Hours Movers TWST Twist Bioscience $145.03 / +7.29 (+5.29%) 02/05/21 Fly Intel: Wall Street's top stories for Friday 02/05/21 Fly Intel: Wall Street's top stories at midday 12/01/20 Fly Intel: After-Hours Movers 11/23/20 Fly Intel: Pre-market Movers PACB Pacific Biosciences $35.25 / +4.68 (+15.31%) 11/03/20 Fly Intel: Pre-market Movers 10/02/20 Fly Intel: Pre-market Movers QGEN Qiagen $50.35 / +0.3 (+0.60%) 02/09/21 Fly Intel: After-Hours Movers 02/08/21 Fly Intel: Wall Street's top stories for Monday 11/11/20 Fly Intel: After-Hours Movers TXG 10x Genomics $186.79 / +8.82 (+4.96%) 10/05/20 Fly Intel: After-Hours Movers 09/08/20 Fly Intel: After-Hours Movers CDXS Codexis $23.48 / +1.3 (+5.86%) 12/03/20 Fly Intel: Wall Street's top stories for Thursday 12/03/20 Fly Intel: Wall Street's top stories at midday 12/03/20 Fly Intel: Pre-market Movers PKI PerkinElmer $129.77 / +3.58 (+2.84%) 01/07/21 Fly Intel: Pre-market Movers ILMN Illumina $446.26 / +6.68 (+1.52%) 10/29/20 Fly Intel: After-Hours Movers 09/21/20 Fly Intel: Wall Street's top stories for Monday 09/21/20 Fly Intel: Wall Street's top stories at midday 09/21/20 Fly Intel: Pre-market Movers RHHBY Roche $0.00 / + (+0.00%) 12/26/20 Week in review: How Trump's policies moved stocks 11/30/20 Fly Intel: Wall Street's top stories for Monday 11/30/20 Fly Intel: Wall Street's top stories at midday 11/21/20 Week in review: How Trump's policies moved stocks BNGO Bionano Genomics $9.84 / +0.105 (+1.08%) 01/19/21 Fly Intel: After-Hours Movers 01/15/21 Fly Intel: Wall Street's top stories at midday 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 00:00 Today 41st Annual Healthcare Virtual Conference 00:00 Today 2021 London Global Healthcare Virtual Conference 03/15/21 33rd Annual Roth Virtual Conference 03/16/21 31st Annual Healthcare Virtual Conference 03/25/21 Roche - RHHBY PACB QGEN PKI ILMN BNGO PACB Pacific Biosciences $35.25 / +4.68 (+15.31%) 01/08/21 Pacific Biosciences call volume above normal and directionally bullish 11/02/20 Pacific Biosciences options imply 18.3% move in share price post-earnings QGEN Qiagen $50.35 / +0.3 (+0.60%) 10/14/20 Call spread buyer crosses wide spread in Qiagen 09/16/20 Largest borrow rate increases among liquid names PKI PerkinElmer $129.77 / +3.58 (+2.84%) 09/11/20 Early notable gainers among liquid option names on September 11th ILMN Illumina $446.26 / +6.68 (+1.52%) 02/12/21 Early notable gainers among liquid option names on February 12th 01/15/21 Early notable gainers among liquid option names on January 15th 12/22/20 Early notable gainers among liquid option names on December 22nd 09/22/20 Illumina call volume above normal and directionally bullish BNGO Bionano Genomics $9.84 / +0.105 (+1.08%) 02/12/21 Bionano Genomics call volume above normal and directionally bullish 02/11/21 Bionano Genomics call volume above normal and directionally bullish 01/26/21 Largest borrow rate increases among liquid names 01/13/21 Thirteen new option listings and two option delistings on January 13th
Conference/Events	Raymond James to hold a virtual conference » 04:55 03/02/21 03/02 04:55 03/02/21 04:55 JLL Jones Lang LaSalle $179.05 / +4.565 (+2.62%) , PODD Insulet $270.70 / +10.41 (+4.00%) , SMG Scotts Miracle-Gro $224.83 / +11.37 (+5.33%) , IDXX Idexx Laboratories $538.76 / +18.79 (+3.61%) , APLS Apellis $47.66 / -0.66 (-1.37%) , AVT Avnet $39.47 / +1.325 (+3.47%) , SBAC SBA Communications $248.08 / -7.18 (-2.81%) , LPTX Leap Therapeutics $2.42 / +0.06 (+2.54%) , RJF Raymond James $120.98 / +4.28 (+3.67%) , WY Weyerhaeuser $35.06 / +1.18 (+3.48%) , LZB La-Z-Boy $42.00 / -0.74 (-1.73%) , DXCM DexCom $397.08 / -2.17 (-0.54%) , ADMA ADMA Biologics $2.41 / +0.095 (+4.11%) , CTT CatchMark Timber $10.59 / +0.39 (+3.82%) , CACI CACI $226.70 / +5.55 (+2.51%) , BR Broadridge $146.44 / +3.88 (+2.72%) , CWST Casella Waste $60.56 / +2.42 (+4.16%) , FLXN Flexion $11.41 / +0.36 (+3.26%) , HOLX Hologic $74.61 / +2.46 (+3.41%) , VSAT ViaSat $52.85 / +1.34 (+2.60%) 42nd Annual Institutional… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options JLL PODD SMG IDXX APLS AVT SBAC LPTX RJF WY LZB DXCM ADMA CACI BR CWST FLXN HOLX VSAT JLL Jones Lang LaSalle $179.05 / +4.565 (+2.62%) 02/17/21 JLL appoints Gilda Perez-Alvarado as global CEO, Hotels & Hospitality 01/25/21 JLL appoints Ingrid Jacobs as head of diversity, inclusion 11/24/20 BP, Jones Lang LaSalle enter multi-year vested workplace evolution agreement 11/20/20 JLL names Rastogi chief product officer to lead JLL Technologies PODD Insulet $270.70 / +10.41 (+4.00%) 02/16/21 Lone Pine bought Snap and Carvana during Q4, exited PayPal 12/28/20 Insulet announces settlement of dispute with Ypsomed AG 09/21/20 Insulet launches Omnipod DASH System in additional countries SMG Scotts Miracle-Gro $224.83 / +11.37 (+5.33%) 02/16/21 Holders of 1.7M AeroGrow shares reject Scotts Miracle-Gro's $3 per share offer 02/03/21 Scotts Miracle-Gro CEO says 'getting close' to raising EPS guidance 01/11/21 Scotts Miracle-Gro CFO Randy Coleman departs 01/05/21 Flowr, Hawthorne Canada announce completion of cannabis R&D facility IDXX Idexx Laboratories $538.76 / +18.79 (+3.61%) 11/10/20 Idexx Laboratories CFO sells 10K shares of common stock APLS Apellis $47.66 / -0.66 (-1.37%) 01/21/21 Apellis says 'on track' for Phase 3 GA results in 3Q21 12/10/20 Swedish Orphan Biovitrum, Apellis report results from PEGASUS study 12/10/20 Apellis and Sobi report top-line Phase 3 results of pegcetacoplan in PNH 12/07/20 Apellis announces new analyses from Phase 3 PEGASUS study AVT Avnet $39.47 / +1.325 (+3.47%) 01/27/21 Avnet jumps over 5% to $39.69 after Q2 earnings beat, above-consensus Q3 view 11/23/20 Avnet names Phil Gallagher CEO SBAC SBA Communications $248.08 / -7.18 (-2.81%) 02/22/21 Dish signs master lease agreement with SBA Communications 02/02/21 PG&E unit sells rights to 700 towers to SBA Communications for $973M 01/24/21 Fly Intel: Top five weekend stock stories LPTX Leap Therapeutics $2.42 / +0.06 (+2.54%) 12/22/20 Leap Therapeutics announces publication of mechanism of action data for DKN-01 11/09/20 Leap Therapeutics presents DKN-01 data at AACR conference 11/09/20 Leap presents data from Phase 1b/2a clinical trial of DKN-01 09/24/20 Leap Therapeutics granted FDA Fast Track Designation for DKN-01 RJF Raymond James $120.98 / +4.28 (+3.67%) 01/27/21 Raymond James reports Q1 client assets under administration $1.02T WY Weyerhaeuser $35.06 / +1.18 (+3.48%) 02/25/21 Weyerhaeuser to acquire Timberlands in Southwest Alabama from Greif 02/17/21 Weyerhaeuser names Nancy Loewe as CFO, effective March 8 01/25/21 Weyerhaeuser to recognize $253M pension settlement charge in Q4 10/30/20 Weyerhaeuser reinitiates quarterly cash dividend LZB La-Z-Boy $42.00 / -0.74 (-1.73%) 02/16/21 La-Z-Boy CEO Kurt Darrow to retire April 25 01/28/21 La-Z-Boy increases quarterly dividend by 1c per share 01/11/21 La-Z-Boy appoints Robert Sundy as chief commercial officer 12/10/20 La-Z-Boy general counsel Stephen Krull to retire DXCM DexCom $397.08 / -2.17 (-0.54%) 02/16/21 Lone Pine bought Snap and Carvana during Q4, exited PayPal 02/12/21 DexCom CEO: Everything about G7 will be better than G6 02/11/21 DexCom launches inaugural venture capital fund 01/14/21 DexCom CEO sells 47K shares of common stock ADMA ADMA Biologics $2.41 / +0.095 (+4.11%) 02/01/21 ADMA Biologics receives FDA approval for Biocenters facility in Knoxville 01/26/21 ADMA Biologics receives unique permanent J-Code for Asceniv 01/19/21 ADMA Biologics announces 2021 key strategic priorities 01/04/21 ADMA receives temporary C-Code, pass-through payment status for ASCENIV CACI CACI $226.70 / +5.55 (+2.51%) 03/01/21 CACI gets prime spot on multiple-award contract for litigation support to DOJ 01/26/21 CACI awarded $96M task order by U.S. Army 12/10/20 Air Force awards CACI $160M task order to provide information technology support 10/22/20 CACI awarded up to $86.5M, five-year DHS contract BR Broadridge $146.44 / +3.88 (+2.72%) 01/28/21 Broadridge begins development to be an approved SFT submitter 12/08/20 Broadridge selected by BEC for updated Shareholder Rights Directive 11/09/20 Broadridge names Edmund Reese as CFO, effective November 30 11/02/20 LiquidX announces multi-year investment from Broadridge CWST Casella Waste $60.56 / +2.42 (+4.16%) 10/14/20 Casella Waste announces Shelley Sayward to assume General Counsel role 10/14/20 Casella Waste announces permit expansion at North Country site 10/02/20 Casella Waste acquires Pinto Trucking Services FLXN Flexion $11.41 / +0.36 (+3.26%) 03/01/21 Flexion announces FDA clearance for FX301 IND application 02/18/21 Flexion to advance FX201 into high dose cohort of Phase 1 trial 02/01/21 NBRPA, Sheryl Swoopes, Flexion partner to raise ZILRETTA awarness 01/13/21 Flexion promotes Adam Muzikant to CBO HOLX Hologic $74.61 / +2.46 (+3.41%) 03/01/21 Hologic acquires Diagenode for $159M, sees accretion after FY22 02/15/21 Fly Intel: Top five weekend stock stories 02/01/21 Hologic, Google Cloud collaborate over digital diagnostic capabilities 01/08/21 Hologic announces new, five-year $1B share repurchase plan VSAT ViaSat $52.85 / +1.34 (+2.60%) 02/10/21 ViaSat, GSS and TMC enter MOU to advance IFC services in Russia 02/09/21 ViaSat awarded $8.5M contract to upgrade UHF SATCOM from Airbus 01/05/21 Delta Air Lines selects ViaSat's Ka-band satellite IFC system 12/21/20 ViaSat to acquire RigNet in $222M all-stock transaction JLL PODD SMG IDXX APLS AVT SBAC LPTX RJF WY LZB DXCM ADMA CTT CACI BR CWST FLXN HOLX VSAT JLL Jones Lang LaSalle $179.05 / +4.565 (+2.62%) 02/26/21 JPMorgan Jones Lang LaSalle price target raised to $200 from $176 at JPMorgan 01/25/21 Goldman Sachs Jones Lang LaSalle initiated with a Buy at Goldman Sachs 12/21/20 JPMorgan Jones Lang LaSalle price target raised to $172 from $132 at JPMorgan 10/07/20 Keefe Bruyette Jones Lang LaSalle downgraded to Market Perform at Keefe Bruyette PODD Insulet $270.70 / +10.41 (+4.00%) 02/25/21 Oppenheimer Insulet price target raised to $277 from $235 at Oppenheimer 02/24/21 Raymond James Insulet price target raised to $296 from $282 at Raymond James 02/04/21 Piper Sandler Tandem trades at 'significant discount' to Insulet, says Piper Sandler 01/29/21 Piper Sandler Insulet downgraded to Neutral from Overweight at Piper Sandler SMG Scotts Miracle-Gro $224.83 / +11.37 (+5.33%) 02/04/21 Truist Scotts Miracle-Gro price target raised to $270 from $250 at Truist 01/11/21 Raymond James Scotts Miracle-Gro price target raised to $274 from $224 at Raymond James 01/07/21 Truist Scotts Miracle-Gro price target raised to $250 from $180 at Truist 12/11/20 Fly Intel: Top five analyst upgrades IDXX Idexx Laboratories $538.76 / +18.79 (+3.61%) 02/17/21 Barclays Idexx Laboratories initiated with an Overweight at Barclays 01/29/21 JPMorgan Idexx Laboratories initiated with an Overweight at JPMorgan 08/17/20 Credit Suisse Idexx Laboratories price target raised to $422 from $415 at Credit Suisse 08/04/20 Credit Suisse Idexx Laboratories price target raised to $415 from $300 at Credit Suisse APLS Apellis $47.66 / -0.66 (-1.37%) 01/29/21 Baird Apellis assumed at Outperform at Baird 12/14/20 Roth Capital Apellis price target raised to $73 from $50 at Roth Capital 12/10/20 Cowen Apellis price target raised to $55 from $45 at Cowen 12/04/20 JPMorgan Apellis price target raised to $87 from $50 at JPMorgan AVT Avnet $39.47 / +1.325 (+3.47%) 02/23/21 Citi Citi opens long Arrow Electronics, short Avnet pair trade 01/29/21 Loop Capital Avnet price target raised to $39 from $32 at Loop Capital 01/19/21 Citi Citi boosts Avnet target to $40, opens 'Positive Catalyst Watch' 12/14/20 Goldman Sachs Avnet price target raised to $25 from $23 at Goldman Sachs SBAC SBA Communications $248.08 / -7.18 (-2.81%) 02/23/21 Credit Suisse SBA Communications price target lowered to $277 from $291 at Credit Suisse 02/23/21 Barclays SBA Communications price target raised to $310 from $305 at Barclays 02/23/21 Deutsche Bank SBA Communications price target lowered to $325 from $335 at Deutsche Bank 02/08/21 JPMorgan JPMorgan downgrades SBA to Neutral on 'lukewarm' tower stance LPTX Leap Therapeutics $2.42 / +0.06 (+2.54%) 01/29/21 Baird Leap Therapeutics assumed at Outperform at Baird 06/29/20 Piper Sandler Leap Therapeutics initiated with an Overweight at Piper Sandler RJF Raymond James $120.98 / +4.28 (+3.67%) 01/29/21 Citi Citi opens 'Positive Catalyst Watch' on Raymond James, ups price target 01/15/21 Wells Fargo Raymond James double upgraded to Overweight at Wells Fargo 01/15/21 Wells Fargo Raymond James upgraded to Overweight from Underweight at Wells Fargo 01/05/21 Wolfe Research Raymond James upgraded to Outperform from Peer Perform at Wolfe Research WY Weyerhaeuser $35.06 / +1.18 (+3.48%) 02/01/21 DA Davidson Weyerhaeuser price target raised to $34 from $29 at DA Davidson 12/04/20 Raymond James Weyerhaeuser upgraded to Outperform from Market Perform at Raymond James 08/03/20 Fly Intel: Top five analyst downgrades 08/03/20 DA Davidson Weyerhaeuser downgraded to Neutral from Buy at DA Davidson LZB La-Z-Boy $42.00 / -0.74 (-1.73%) 11/19/20 Raymond James La-Z-Boy price target raised to $46 from $37 at Raymond James 10/19/20 Sidoti La-Z-Boy upgraded to Buy from Neutral at Sidoti 06/25/20 Stifel La-Z-Boy price target raised to $37 from $25 at Stifel 04/13/20 Sidoti La-Z-Boy downgraded to Neutral from Buy at Sidoti DXCM DexCom $397.08 / -2.17 (-0.54%) 02/12/21 Oppenheimer DexCom price target raised to $449 from $415 at Oppenheimer 02/12/21 Citi DexCom price target lowered to $480 from $485 at Citi 02/12/21 Piper Sandler DexCom earnings selloff should be bought, says Piper Sandler 01/29/21 Piper Sandler DexCom price target raised to $500 from $465 at Piper Sandler ADMA ADMA Biologics $2.41 / +0.095 (+4.11%) 10/01/20 Raymond James ADMA Biologics price target raised to $9 from $7 at Raymond James 09/30/20 Jefferies ADMA Biologics shares 'in arbitrage territory,' says Jefferies 05/26/20 Maxim ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim 05/07/20 Oppenheimer ADMA Biologics price target lowered to $7 from $14 at Oppenheimer CTT CatchMark Timber $10.59 / +0.39 (+3.82%) 02/16/21 B. Riley Securities CatchMark Timber price target raised to $12.50 from $11 at B. Riley 02/12/21 RBC Capital CatchMark Timber cut to Sector Perform at RBC Capital on more limited growth 02/12/21 RBC Capital CatchMark Timber downgraded to Sector Perform from Outperform at RBC Capital 10/30/20 RBC Capital CatchMark Timber upgraded to Outperform from Sector Perform at RBC Capital CACI CACI $226.70 / +5.55 (+2.51%) 02/23/21 William Blair William Blair reiterates Outperform on Leidos following quarterly results 01/29/21 Truist CACI price target raised to $290 from $275 at Truist 01/27/21 Stifel CACI 'very likely' to bid on Perspecta as well, says Stifel 09/22/20 JPMorgan JPMorgan upgrades 'relatively resilient' CACI to Overweight BR Broadridge $146.44 / +3.88 (+2.72%) 02/03/21 BTIG Broadridge upgraded to Buy from Neutral at BTIG 12/18/20 Truist Broadridge initiated with a Buy at Truist 12/18/20 Truist Broadridge initiated with a Buy at Truist 08/17/20 JPMorgan Broadridge price target raised to $152 from $142 at JPMorgan CWST Casella Waste $60.56 / +2.42 (+4.16%) 12/21/20 Fly Intel: Top five analyst initiations 12/21/20 BofA Casella Waste initiated with a Neutral at BofA 10/15/20 Berenberg Casella Waste initiated with a Buy at Berenberg 09/24/20 Stifel Casella Waste upgraded to Buy at Stifel, in a position to sustain 7%-8% growth FLXN Flexion $11.41 / +0.36 (+3.26%) 08/20/20 Goldman Sachs Flexion initiated with a Neutral at Goldman Sachs 07/30/20 Oppenheimer Flexion initiated with an Outperform at Oppenheimer 07/29/20 Fly Intel: Top five analyst initiations 07/29/20 Credit Suisse Flexion initiated with an Outperform at Credit Suisse HOLX Hologic $74.61 / +2.46 (+3.41%) 02/22/21 BTIG Hologic price target raised to $91 from $84 at BTIG 01/28/21 Wells Fargo Hologic price target raised to $95 from $90 at Wells Fargo 12/08/20 Argus Hologic price target raised to $100 from $85 at Argus 11/20/20 Fly Intel: Top five analyst downgrades VSAT ViaSat $52.85 / +1.34 (+2.60%) 02/12/21 Barclays ViaSat price target raised to $65 from $53 at Barclays 02/05/21 William Blair William Blair upgrades ViaSat, sees upside to $90-$110 per share 02/05/21 William Blair ViaSat upgraded to Outperform from Market Perform at William Blair 01/07/21 William Blair ViaSat win at Delta likely brings large upfront cost, says William Blair JLL PODD SMG IDXX APLS AVT SBAC LPTX RJF WY LZB DXCM ADMA CTT CACI BR CWST FLXN HOLX VSAT JLL Jones Lang LaSalle $179.05 / +4.565 (+2.62%) 02/09/21 Jones Lang LaSalle reports Q4 adjusted EPS $5.29 vs. $6.35 a year ago 02/09/21 Jones Lang LaSalle reports Q4 adjusted EPS $5.29, consensus $3.93 11/02/20 Jones Lang LaSalle reports Q3 adjusted EPS $2.99, consensus $1.25 11/02/20 Jones Lang LaSalle reports Q3 adjusted EPS $2.99, consensus $1.25 PODD Insulet $270.70 / +10.41 (+4.00%) 02/23/21 Insulet reports Q4 EPS (26c), consensus (4c) 11/04/20 Insulet raises FY20 revenue growth guidance to 20%-21% from 17%-19% 11/04/20 Insulet reports Q3 EPS 17c, consensus 8c SMG Scotts Miracle-Gro $224.83 / +11.37 (+5.33%) 03/01/21 Scotts Miracle-Gro sees exceeding prior FY EPS guidance of $8.00-$8.40 02/03/21 Scotts Miracle-Gro sees 2021 adjusted EPS $8.00-$8.40, consensus $8.26 02/03/21 Scotts Miracle-Gro reports Q1 adjusted EPS 39c, consensus (76c) 11/04/20 Scotts Miracle-Gro sees FY21 sales growth 0%-5%, consensus $4.17B IDXX Idexx Laboratories $538.76 / +18.79 (+3.61%) 02/02/21 Idexx Laboratories sees FY21 EPS $7.39-$7.71, consensus $6.81 02/02/21 Idexx Laboratories reports Q4 EPS $2.01 with items, consensus $1.40 10/29/20 Idexx Laboratories reports Q3 EPS $1.69, consensus $1.43 APLS Apellis $47.66 / -0.66 (-1.37%) 02/25/21 Apellis reports Q EPS 93c, consensus (75c) 11/02/20 Apellis reports Q3 EPS ($1.79), consensus ($1.58) AVT Avnet $39.47 / +1.325 (+3.47%) 01/27/21 Avnet sees Q3 adjusted EPS 52c-58c, consensus 48c 01/27/21 Avnet reports Q2 adjusted EPS 48c, consensus 39c 01/27/21 Notable companies reporting after market close 10/28/20 Avnet sees Q2 EPS 33c-43c, consensus 34c SBAC SBA Communications $248.08 / -7.18 (-2.81%) 02/22/21 SBA Communications sees FY21 AFFO $10-$10.41, consensus $10.12 02/22/21 SBA Communications reports Q4 AFFO $2.49, consensus $2.44 11/02/20 SBA Communications raises FY20 AFFO view to $9.27-$9.50 from $8.94-$9.33 11/02/20 SBA Communications reports Q3 AFFO $2.38, consensus $2.32 LPTX Leap Therapeutics $2.42 / +0.06 (+2.54%) 11/12/20 Leap Therapeutics reports Q3 EPS (9c), consensus (13c) RJF Raymond James $120.98 / +4.28 (+3.67%) 01/27/21 Raymond James reports Q1 adjusted EPS 2.24, consensus $1.72 WY Weyerhaeuser $35.06 / +1.18 (+3.48%) 01/29/21 Weyerhaeuser reports Q4 ex-items EPS 48c, consensus 46c 10/30/20 Weyerhaeuser reports Q3 ex-items EPS 52c, consensus 47c LZB La-Z-Boy $42.00 / -0.74 (-1.73%) 02/16/21 La-Z-Boy sees Q4 revenue up 34%-39%, consensus $509.85M 02/16/21 La-Z-Boy reports Q3 EPS 74c, consensus 70c 01/28/21 La-Z-Boy sees Q3 consolidated sales down 1%-2% year-over-year 11/17/20 La-Z-Boy sees Q3 revenue flat to up 4%, consensus $512M DXCM DexCom $397.08 / -2.17 (-0.54%) 02/11/21 DexCom sees FY21 revenue $2.21B-$2.31B, consensus $2.33B 02/11/21 DexCom reports Q4 EPS $3.48, consensus 92c 01/11/21 DexCom sees FY20 revenue $1.93B, consensus $1.91B 01/11/21 DexCom reports preliminary Q4 revenue at least $567M, consensus $550.73M ADMA ADMA Biologics $2.41 / +0.095 (+4.11%) 01/19/21 ADMA Biologics sees FY20 revenue $42.2M, consensus $40.33M 01/19/21 ADMA Biologics sees Q4 revenue $13.9M, consensus $12.05M CTT CatchMark Timber $10.59 / +0.39 (+3.82%) 02/11/21 CatchMark Timber reports Q4 EPS (6c), consensus (4c) 10/29/20 CatchMark Timber reports Q3 EPS (9c), consensus (8c) CACI CACI $226.70 / +5.55 (+2.51%) 01/27/21 CACI sees FY21 EPS $14.47-$15.25, consensus $15.01 01/27/21 CACI reports Q2 EPS $4.18, consensus $3.60 10/28/20 CACI raises FY21 EPS view to $14.47-$15.25 from $13.50-$14.28 10/28/20 CACI reports Q1 EPS $3.67, consensus $3.11 BR Broadridge $146.44 / +3.88 (+2.72%) 02/02/21 Broadridge reports Q2 adjusted EPS 73c, consensus 70c 12/10/20 Broadridge backs FY21 adjusted EPS growth of 6%-10%, consensus $5.50 12/10/20 Broadridge targets adjusted EPS growth FY20-FY23 of 8%-12% 10/30/20 Broadridge reports Q1 adjusted EPS 98c, consensus 63c CWST Casella Waste $60.56 / +2.42 (+4.16%) 02/18/21 Casella Waste sees FY21 revenue $815M-$830M, consensus $832.21M 02/18/21 Casella Waste reports Q4 adjusted EPS 17c, consensus 14c 10/29/20 Casella Waste raises FY20 revenue view to $760M-$775M from $755M-$770M 10/29/20 Casella Waste reports Q3 EPS 31c, consensus 29c FLXN Flexion $11.41 / +0.36 (+3.26%) 01/13/21 Flexion sees 2020 revenue $85.5M, consensus $84.88M 01/13/21 Flexion sees Q4 revenue $26.3M, consensus $25.66M 11/04/20 Flexion reports Q3 EPS (50c), consensus (51c) HOLX Hologic $74.61 / +2.46 (+3.41%) 01/27/21 Hologic sees Q2 adjusted EPS $2.56-$2.68, consensus $2.02 01/27/21 Hologic reports Q1 adjusted EPS $2.86, consensus $2.17 01/27/21 Notable companies reporting after market close 01/08/21 Hologic reports preliminary Q1 revenue $1.61B, consensus $1.38B VSAT ViaSat $52.85 / +1.34 (+2.60%) 02/04/21 ViaSat reports Q3 non-GAAP EPS 39c, may not compare to consensus (1c) 11/05/20 ViaSat reports Q2 adjusted EPS 31c, consensus (7c) 21 Oct 18 Jun 21 May 13 May SMG SBAC RJF HOLX SMG Scotts Miracle-Gro $224.83 / +11.37 (+5.33%) 01/22/21 DoorDash, Fiverr to advertise in Super Bowl for first time, WSJ says SBAC SBA Communications $248.08 / -7.18 (-2.81%) 01/23/21 SBA, Equinix among names to buy in year of digital infrastructure, Barron's says RJF Raymond James $120.98 / +4.28 (+3.67%) 09/16/20 Raymond James lays off 4% of staff, or 500 employees, Advisor Hub reports HOLX Hologic $74.61 / +2.46 (+3.41%) 02/13/21 Hologic looks cheap, time to buy, Barron's says SMG APLS LZB DXCM CWST HOLX VSAT SMG Scotts Miracle-Gro $224.83 / +11.37 (+5.33%) 12/13/20 Opening Day: Airbnb shares double in IPO, DoorDash soars in debut 11/04/20 Fly Intel: Pre-market Movers 09/14/20 Fly Intel: After-Hours Movers APLS Apellis $47.66 / -0.66 (-1.37%) 12/14/20 Fly Intel: Wall Street's top stories for Monday 12/14/20 Fly Intel: Wall Street's top stories at midday LZB La-Z-Boy $42.00 / -0.74 (-1.73%) 02/16/21 Fly Intel: After-Hours Movers 11/18/20 Fly Intel: Pre-market Movers 11/17/20 Fly Intel: After-Hours Movers DXCM DexCom $397.08 / -2.17 (-0.54%) 02/11/21 Fly Intel: After-Hours Movers 01/11/21 Fly Intel: Pre-market Movers 10/26/20 Fly Intel: After-Hours Movers 10/02/20 DexCom downgrade, Shake Shack initiation among today's top calls on Wall Street CWST Casella Waste $60.56 / +2.42 (+4.16%) 10/20/20 Fly Intel: After-Hours Movers 10/02/20 Fly Intel: Pre-market Movers HOLX Hologic $74.61 / +2.46 (+3.41%) 01/27/21 Fly Intel: After-Hours Movers 11/20/20 Nikola initiation at Loop among today's top calls on Wall Street VSAT ViaSat $52.85 / +1.34 (+2.60%) 11/18/20 Boeing rises after FAA lifts order grounding 737 MAX 11/05/20 Fly Intel: After-Hours Movers 00:00 Today 41st Annual Healthcare Virtual Conference 03/16/21 31st Annual Healthcare Virtual Conference 03/18/21 Waste & Environmental Services Virtual Symposium 03/03/21 Jones Lang LaSalle - JLL 05/14/21 PDUFA Date for Pegcetacoplan 03/11/21 Hologic Inc IDXX WY ADMA HOLX IDXX Idexx Laboratories $538.76 / +18.79 (+3.61%) 02/02/21 Early notable gainers among liquid option names on February 2nd WY Weyerhaeuser $35.06 / +1.18 (+3.48%) 12/21/20 Weyerhaeuser call volume above normal and directionally bullish 09/29/20 Weyerhaeuser put volume heavy and directionally bearish ADMA ADMA Biologics $2.41 / +0.095 (+4.11%) 11/06/20 Largest borrow rate increases among liquid names 09/30/20 Largest borrow rate increases among liquid names 09/28/20 Largest borrow rate increases among liquid names HOLX Hologic $74.61 / +2.46 (+3.41%) 02/01/21 Early notable gainers among liquid option names on February 1st 01/08/21 Early notable gainers among liquid option names on January 8th 10/26/20 Early notable gainers among liquid option names on October 26th 09/11/20 Early notable gainers among liquid option names on September 11th
Conference/Events	Vaxart to host conference call » 04:55 03/02/21 03/02 04:55 03/02/21 04:55 VXRT Vaxart $7.55 / +0.38 (+5.30%) Management holds a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options VXRT Vaxart $7.55 / +0.38 (+5.30%) 02/03/21 Vaxart trading resumes 02/03/21 Vaxart trading halted, volatility trading pause 02/03/21 Vaxart announces preliminary data from Phase 1 trial of oral COVID-19 tablet 01/27/21 Vaxart announces publication on healh care economic findings VXRT Vaxart $7.55 / +0.38 (+5.30%) 11/18/20 B. Riley Securities Vaxart price target lowered to $16 from $22 at B. Riley Securities 10/13/20 B. Riley Securities B. Riley views Vaxart as key player in 'second wave' of Covid vaccines 09/09/20 B. Riley FBR Astra trial hold opens window for other vaccine candidates, says B. Riley FBR 08/12/20 H.C. Wainwright Vaxart price target raised to $17 from $7 at H.C. Wainwright VXRT Vaxart $7.55 / +0.38 (+5.30%) 11/12/20 Vaxart reports Q3 EPS (8c), consensus (9c) VXRT Vaxart $7.55 / +0.38 (+5.30%) 02/03/21 Fly Intel: Wall Street's top stories for Wednesday 02/03/21 Fly Intel: Wall Street's top stories at midday 01/26/21 Fly Intel: Wall Street's top stories for Tuesday 01/26/21 Fly Intel: Wall Street's top stories at midday 16:30 Today Vaxart - VXRT VXRT Vaxart $7.55 / +0.38 (+5.30%) 02/25/21 Vaxart options imply 19.5% move in share price post-earnings 02/05/21 Largest borrow rate increases among liquid names 01/29/21 Vaxart call volume above normal and directionally bullish 01/26/21 Unusually active option classes on open January 26th
Conference/Events	Cogent Communications to participate in a conference call with Cowen » 04:55 03/02/21 03/02 04:55 03/02/21 04:55 CCOI Cogent $60.25 / -0.02 (-0.03%) Communications Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CCOI Cogent $60.25 / -0.02 (-0.03%) 11/05/20 Cogent increases dividend 3.5% to 73c per share CCOI Cogent $60.25 / -0.02 (-0.03%) 02/03/21 MoffettNathanson Cogent upgraded to Buy on reopening and recovery at MoffettNathanson 02/03/21 MoffettNathanson Cogent upgraded to Buy from Neutral at MoffettNathanson 11/17/20 RBC Capital Cogent price target lowered to $70 from $79 at RBC Capital 11/04/20 Citi Cogent price target lowered to $75 from $89 at Citi CCOI Cogent $60.25 / -0.02 (-0.03%) 11/05/20 Cogent reports Q3 EPS (11c), consensus 22c 14:00 Today Cogent - CCOI 03/05/21 Cogent
Conference/Events	Morgan Stanley to hold a virtual conference » 04:55 03/02/21 03/02 04:55 03/02/21 04:55 CEQP Crestwood Equity $23.08 / +1.09 (+4.96%) , EPD Enterprise Products $22.37 / +1.045 (+4.90%) , SEDG SolarEdge $307.87 / +8.87 (+2.97%) , PNW Pinnacle West $72.32 / +2.37 (+3.39%) Energy & Power… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options EPD SEDG PNW EPD Enterprise Products $22.37 / +1.045 (+4.90%) 03/01/21 EDF Renewables signs virtual power ppurchase agreement with Enterprise Products 02/03/21 Enterprise Products sees 2021 growth CapEx $1.6B 01/21/21 Enterprise Products, Magellan Midstream to develop Houston crude oil futures 09/09/20 Enterprise Products cancelling Echo 4 pipeline project SEDG SolarEdge $307.87 / +8.87 (+2.97%) 02/23/21 SolarEdge enters supply agreement with Sunrun 02/16/21 SolarEdge to supply electrical powertrain, battery solution for Fiat E-Ducato 12/23/20 SolarEdge appoints Yogev Barak as Chief Marketing Officer 11/02/20 SolarEdge falls 12% to $234.44 after below-consensus Q3 revenue, Q4 guidance PNW Pinnacle West $72.32 / +2.37 (+3.39%) 12/16/20 Nikola plans deal with Pinnacle West unit for energy in Arizona, Bloomberg says 10/22/20 Pinnacle West raises quarterly dividend 6.1% to 83c per share CEQP EPD SEDG PNW CEQP Crestwood Equity $23.08 / +1.09 (+4.96%) 02/26/21 Wells Fargo Crestwood Equity upgraded at Wells Fargo on 'solid' 2021 outlook 02/26/21 Wells Fargo Crestwood Equity upgraded to Equal Weight from Underweight at Wells Fargo 02/16/21 Truist Crestwood Equity upgraded to Buy from Hold at Truist 02/16/21 Truist Crestwood Equity upgraded to Buy from Hold at Truist EPD Enterprise Products $22.37 / +1.045 (+4.90%) 01/20/21 Mizuho Enterprise Products price target raised to $27 from $24 at Mizuho 12/03/20 SMBC Nikko Enterprise Products initiated with an Outperform at SMBC Nikko 11/23/20 Wolfe Research Enterprise Products upgraded to Outperform from Peer Perform at Wolfe Research 11/13/20 Evercore ISI Enterprise Products upgraded to Outperform from In Line at Evercore ISI SEDG SolarEdge $307.87 / +8.87 (+2.97%) 02/18/21 Canaccord SED International price target raised to $350 from $200 at Canaccord 02/17/21 Northland SolarEdge price target raised to $210 from $195 at Northland 02/17/21 Roth Capital SolarEdge price target raised to $380 from $340 at Roth Capital 02/17/21 B. Riley Securities SolarEdge price target raised to $371 from $367 at B. Riley Securities PNW Pinnacle West $72.32 / +2.37 (+3.39%) 02/25/21 Credit Suisse Pinnacle West downgraded to Neutral from Outperform at Credit Suisse 01/19/21 Credit Suisse Pinnacle West price target lowered to $86 from $92 at Credit Suisse 01/06/21 Wells Fargo Wells Fargo says buy CenterPoint Energy, sell FirstEnergy 11/18/20 Barclays Pinnacle West price target raised to $103 from $89 at Barclays CEQP EPD SEDG PNW CEQP Crestwood Equity $23.08 / +1.09 (+4.96%) 02/23/21 Crestwood Equity reports Q4 EPS 3c, consensus 31c 10/27/20 Crestwood Equity sees Q4 revenue to exceed midpoint of $520M-$570M 10/27/20 Crestwood Equity reports Q3 EPS (28c), consensus (6c) EPD Enterprise Products $22.37 / +1.045 (+4.90%) 02/03/21 Enterprise Products reports Q4 EPS 15c, consensus 50c 10/28/20 Enterprise Products reports Q3 EPS 48c, consensus 48c SEDG SolarEdge $307.87 / +8.87 (+2.97%) 02/16/21 SolarEdge sees Q1 revenue $385M-$405M, consensus $377.91M 02/16/21 SolarEdge reports Q4 EPS 98c, consensus 86c 02/16/21 Notable companies reporting after market close 11/02/20 SolarEdge sees Q4 revenue $345M-$365M, consensus $389.57M PNW Pinnacle West $72.32 / +2.37 (+3.39%) 02/24/21 Pinnacle West reports Q4 EPS (17c), consensus 4c 10/30/20 Pinnacle West raises FY20 EPS view to $4.95-$5.15 from $4.75-$4.95 10/30/20 Pinnacle West reports Q3 EPS $3.07, consensus $2.85 PNW PNW Pinnacle West $72.32 / +2.37 (+3.39%) 12/16/20 Nikola planning to buy cheap power in Arizona to make hydrogen, Bloomberg says SEDG PNW SEDG SolarEdge $307.87 / +8.87 (+2.97%) 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 02/20/21 Charged: Analyst sees Apple announcing EV partnership in 2021 02/16/21 Fly Intel: After-Hours Movers 02/13/21 Charged: Tesla discloses $1.5B bitcoin investment PNW Pinnacle West $72.32 / +2.37 (+3.39%) 12/19/20 Charged: Deutsche sees multiple EV winners, says buy Xpev 03/03/21 Alternative Energy 03/03/21 Enterprise Products 03/04/21 Enterprise Products 03/08/21 Pinnacle West 03/09/21 Pinnacle West 12/06/21 Pinnacle West EPD SEDG EPD Enterprise Products $22.37 / +1.045 (+4.90%) 01/25/21 Enterprise Products put volume heavy and directionally bearish 12/23/20 Largest borrow rate increases among liquid names 11/18/20 Enterprise Products call volume above normal and directionally bullish 11/13/20 Enterprise Products call volume above normal and directionally bullish SEDG SolarEdge $307.87 / +8.87 (+2.97%) 02/16/21 SolarEdge options imply 17.9% move in share price post-earnings

Events

Earnings calls, analyst events, roadshows and more

AMADY
Today at 07:30

Amadeus IT Group - AMADY Conference Calls
SE
Today at 07:30

Sea Limited - SE Conference Calls
MBI
Today at 08:00

MBIA - MBI Conference Calls
CHS
Today at 08:00

Chico's - CHS Conference Calls
TILE
Today at 08:00

Interface - TILE Conference Calls
LL
Today at 08:00

Lumber Liquidators - LL Conference Calls
IGT
Today at 08:00

International Game - IGT Conference Calls
FSK
Today at 08:00

FS KKR Capital - FSK Conference Calls
FOE
Today at 08:00

Ferro - FOE Conference Calls
LMND
Today at 08:00

Lemonade - LMND Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley $84.00-84.50 1.2M Shares KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan $124.96 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley $11.88-12.00 30M Shares FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley $166.50-169.95 1.5M Shares HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan $88.25-89.25 1.45M Shares JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs $30.60 7M Shares RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright $9.23 1.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 12M Shares OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB $32.00-34.00 31M Shares ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler $5.25 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: Wells Fargo, Raymond James $141.28 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson $45.99 4.5M Shares HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler $201.39 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan $62.68 1.75M Shares MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital $84.85 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans $17.00-19.00 16.667M Shares AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton $32.22 10.6M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Conn's reports Q1 non-GAAP EPS ($1.89), consensus (32c)

TODAY'S FREE FLY STORIES

Get Full Fly Access